Page 59 - Prostate News Today

The patient may not have enough information about his or her condition. This requires better communication on the part of the caregiver and the healthcare provider and also having more coordinators who can work to address these issues on a regular basis, they added.

Belzutifan significantly reduced the risk of progression of clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer, in patients previously treated with immune checkpoint inhibitors and anti-angiogenic therapies compared with everolimus in a phase 3 clinical trial.

SARS-CoV-2 infection linked to increased benign prostatic hyperplasia (BPH) complications and medication use. Urological manifestations in COVID-19 patients emphasize the importance of awareness among clinicians.

Cancer is a disease that affects so many lives. More often than not, it seems like a death sentence which is a heavy burden for the patient to carry. It's obviously also devastating news for loved ones such as friends and family.

A new Corewell Health study suggests that men who have longer prostatic urethras, the part of the urethra that travels through the prostate, may be at a higher risk of experiencing moderate, often chronic urinary side effects after receiving radiation for prostate cancer.

Research published in the Journal of Internal Medicine indicates that SARS-CoV-2 infection may worsen lower urinary tract symptoms (LUTS) in men.

Cedars-Sinai Cancer investigators have identified two promising new treatment options for men with recurrent prostate cancer-; both of which helped patients live longer without their disease progressing than the current standard treatment.

New University of Dundee research which combined ultrasound and MRI technology can help detect prostate cancer at an earlier stage and potentially save lives, according to scientists. Click to read more...

New University of Dundee research which combined ultrasound and MRI technology can help detect prostate cancer at an earlier stage and potentially save lives, according to scientists. Click to read more...

The National Cancer Institute awarded investigators at Huntsman Cancer Institute a grant totaling more than $3 million to conduct a clinical trial to see if combining creatine monohydrate supplementation and resistance exercise training helps preserve muscle in people who have metastatic prostate cancer.